Exim Routes IPO GMP, Subscription & Allotment Status Today
Exim Routes is a SME IPO with a price band of Rs 83.00 to Rs 88.00 that listed on 19 Dec 2025 at a listing gain of +25.00%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹83.00 - ₹88.00
- Lot Size
- TBA
- Bidding Closes
- 11 Dec 2025
- Listing Date
- 19 Dec 2025
Complete IPO information
| Current GMP | ₹22 |
|---|---|
| Estimated Listing Gain | +25.00% |
| Price Band | ₹83.00 - ₹88.00 |
| Issue Price | Approx ₹88.00 Crores |
| Listing Price | ₹110.00 |
| Lot Size | TBA |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 19 Dec 2025 |
| Minimum Investment | TBA |
Compare Exim Routes IPO with similar IPOs
IPO Snapshot & Investor Takeaways
The latest recorded Grey Market Premium for Exim Routes stands at ₹22, implying an estimated listing gain of around 25.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
IPO roadmap at a glance
Daily GMP status
Trend chart builds up as more daily GMP snapshots are recorded.
| Date | GMP | Change | Gain |
|---|---|---|---|
| 06 Jan 2026 | ₹22.00 | - | 25.00% |
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | - | - |
| Retail Maximum | - | - | - |
| S-HNI Minimum | - | - | - |
| S-HNI Maximum | - | - | - |
| B-HNI Minimum | - | - | - |
Objects of the Issue & Official Documents
Important takeaways before applying
Listed at 110.0 for 25.00% gains
Exim Routes IPO FAQs
Comments
Share a useful question or insight about Exim Routes.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...